SPO2 VALIDATION STUDY - PHILIPS FAST 2025

NCT07221526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2026-04-01

No results posted yet for this study

Summary

Clinical investigation is to validate the SpO2 accuracy of the M1133AX5, M1133AX6, and AlarX4 (nasal ala application) SpO2 sensors under test with the Philips FAST Pulse Oximetry technology.

Conditions

  • PULSE OXIMETRY

Interventions

DEVICE

NO INTERVENTION

NO INTERVENTION

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Monica Rabanal, NP · Element Desaturation Lab

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-28
Primary Completion
2026-02-05
Completion
2026-02-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07221526 on ClinicalTrials.gov